Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.

OBJECTIVE:To evaluate the effectiveness and toxicities in T4 nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy (IMRT) combined with chemotherapy. METHODS:This is a retrospective analysis of 81 patients treated with intensity-modulated radiotherapy (IMRT). All the primary tumors w...

Full description

Bibliographic Details
Main Authors: Fang-Fang Kong, Hongmei Ying, Cheng-Run Du, Shuang Huang, Jun-Jun Zhou, Chao-Su Hu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3946722?pdf=render
id doaj-8c15f6b6540042268f40416a087842ae
record_format Article
spelling doaj-8c15f6b6540042268f40416a087842ae2020-11-25T01:26:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0193e9136210.1371/journal.pone.0091362Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.Fang-Fang KongHongmei YingCheng-Run DuShuang HuangJun-Jun ZhouChao-Su HuChao-Su HuOBJECTIVE:To evaluate the effectiveness and toxicities in T4 nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy (IMRT) combined with chemotherapy. METHODS:This is a retrospective analysis of 81 patients treated with intensity-modulated radiotherapy (IMRT). All the primary tumors were attributed to T4 stage according to the AJCC2010 staging system. And the distribution of disease by N stage was N0 in 13.6%, N1 in 30.9%, N2 in 37%, and N3 in 18.5%. Cisplatin-based chemotherapy was offered to all patients. Radiotherapy-related toxicities were graded according to the Acute and the Late Radiation Morbidity Scoring Criteria of the Radiation Therapy Oncology Group (RTOG) scoring criteria. Chemotherapy-related toxicities were graded by National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 3.0. Prognostic factors were assessed by univariate analysis. RESULTS:With a median follow-up of 37 months, 12 patients experienced local regional failure and total distant metastasis occurred in 18 patients, representing the major mode of failure. Ten patients died. Among them, 70% died of distant metastasis. The 3-year actuarial rates of local failure-free survival (LFFS), regional failure-free survival (RFFS), distant failure-free survival (DFFS), overall survival (OS), and progression-free survival (PFS) were 83.8%, 97.4%, 81.3%, 90%, and 69.7%, respectively. Acute and late toxicities were mild or moderate. CONCLUSIONS:IMRT provides excellent local-regional control for T4 NPC. Distant metastasis remains the major cause of treatment failure. Further explorations of the sequence and regimen of systemic therapy are needed in the future.http://europepmc.org/articles/PMC3946722?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Fang-Fang Kong
Hongmei Ying
Cheng-Run Du
Shuang Huang
Jun-Jun Zhou
Chao-Su Hu
Chao-Su Hu
spellingShingle Fang-Fang Kong
Hongmei Ying
Cheng-Run Du
Shuang Huang
Jun-Jun Zhou
Chao-Su Hu
Chao-Su Hu
Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.
PLoS ONE
author_facet Fang-Fang Kong
Hongmei Ying
Cheng-Run Du
Shuang Huang
Jun-Jun Zhou
Chao-Su Hu
Chao-Su Hu
author_sort Fang-Fang Kong
title Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.
title_short Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.
title_full Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.
title_fullStr Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.
title_full_unstemmed Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.
title_sort effectiveness and toxicities of intensity-modulated radiation therapy for patients with t4 nasopharyngeal carcinoma.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description OBJECTIVE:To evaluate the effectiveness and toxicities in T4 nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy (IMRT) combined with chemotherapy. METHODS:This is a retrospective analysis of 81 patients treated with intensity-modulated radiotherapy (IMRT). All the primary tumors were attributed to T4 stage according to the AJCC2010 staging system. And the distribution of disease by N stage was N0 in 13.6%, N1 in 30.9%, N2 in 37%, and N3 in 18.5%. Cisplatin-based chemotherapy was offered to all patients. Radiotherapy-related toxicities were graded according to the Acute and the Late Radiation Morbidity Scoring Criteria of the Radiation Therapy Oncology Group (RTOG) scoring criteria. Chemotherapy-related toxicities were graded by National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 3.0. Prognostic factors were assessed by univariate analysis. RESULTS:With a median follow-up of 37 months, 12 patients experienced local regional failure and total distant metastasis occurred in 18 patients, representing the major mode of failure. Ten patients died. Among them, 70% died of distant metastasis. The 3-year actuarial rates of local failure-free survival (LFFS), regional failure-free survival (RFFS), distant failure-free survival (DFFS), overall survival (OS), and progression-free survival (PFS) were 83.8%, 97.4%, 81.3%, 90%, and 69.7%, respectively. Acute and late toxicities were mild or moderate. CONCLUSIONS:IMRT provides excellent local-regional control for T4 NPC. Distant metastasis remains the major cause of treatment failure. Further explorations of the sequence and regimen of systemic therapy are needed in the future.
url http://europepmc.org/articles/PMC3946722?pdf=render
work_keys_str_mv AT fangfangkong effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma
AT hongmeiying effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma
AT chengrundu effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma
AT shuanghuang effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma
AT junjunzhou effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma
AT chaosuhu effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma
AT chaosuhu effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma
_version_ 1725107675200487424